Takeda - PDFSEARCH.IO - Document Search Engine

Takeda
Results: 516

#	Item
401	Financial Results for FY2013 DATA BOOK Takeda Pharmaceutical Company Limited (TSE code[removed]Contact: Corporate Communications Dept. TEL: +[removed] Add to Reading List Source URL: www.takeda.com Language: English - Date: 2014-05-20 03:40:12 Business Financial statements Fundamental analysis Cash flow Financial regulation International Financial Reporting Standards Takeda Pharmaceutical Company Pharmaceutical industry Cash flow statement Accountancy Finance Generally Accepted Accounting Principles
402	Summary of Financial Statements for the Six Month Period Ended September 30, 2013 (Japan GAAP, Consolidated) October 31, 2013 Takeda Pharmaceutical Company Limited Add to Reading List Source URL: www.takeda.com Language: English - Date: 2013-10-30 23:58:40 Eli Lilly and Company Takeda Pharmaceutical Company Pyridines Thiazolidinediones Pharmaceuticals policy Pharmaceutical industry Pioglitazone International Financial Reporting Standards Food and Drug Administration Pharmaceutical sciences Chemistry Pharmacology
403	R&D Initiatives at Takeda Dr. Tadataka Yamada Chief Medical & Scientific Officer May 8, 2014 Add to Reading List Source URL: www.takeda.com Language: English - Date: 2014-05-08 00:41:44 Lymphoma Monoclonal antibodies Amides Bortezomib Pyrazines Brentuximab vedotin Mantle cell lymphoma Alogliptin Multiple myeloma Chemistry Medicine Organic chemistry
404	Consolidated Financial Results for the Fiscal Year 2013 and Guidance for Sustainable Growth François-Xavier Roger Chief Financial Officer May 8, 2014 Add to Reading List Source URL: www.takeda.com Language: English - Date: 2014-05-08 00:41:44 Financial regulation International Financial Reporting Standards Japanese yen Income statement Account Working capital Accountancy Finance Business
405	Summary of Financial Statements for the Nine Month Period Ended December 31, 2013 (Japan GAAP, Consolidated) February 5, 2014 Takeda Pharmaceutical Company Limited Add to Reading List Source URL: www.takeda.com Language: English - Date: 2014-02-04 21:55:20 Takeda Pharmaceutical Company Pyridines Thiazolidinediones Pharmacy Pharmaceutical industry Pioglitazone International Financial Reporting Standards Food and Drug Administration Financial ratio Pharmaceutical sciences Pharmacology Clinical research
406	[removed]Mid-Range Growth Strategy[removed]update) Yasuchika Hasegawa President & CEO Add to Reading List Source URL: www.takeda.com Language: English - Date: 2014-05-08 00:41:44 Compound annual growth rate Finance Business law Dividend Forward-looking statement
407	Consolidated financial results for the 6 month period ended September 30, 2013 François-Xavier Roger Corporate Officer, Senior Vice President, Chief Financial Officer Add to Reading List Source URL: www.takeda.com Language: English - Date: 2013-10-31 02:28:08 Generally Accepted Accounting Principles Financial statements Cash flow Fundamental analysis Japanese yen Income statement Earnings before interest taxes depreciation and amortization International Financial Reporting Standards Income Accountancy Finance Business
408	2014 年 9 月公益財団法人武田科学振興財団武田科学振興財団、「2014 年度武田医学賞」受賞者を発表 Add to Reading List Source URL: www.takeda-sci.or.jp Language: Japanese - Date: 2014-09-28 21:31:48
409	Financial Results st for 1 Half FY2014 DATA BOOK Takeda Pharmaceutical Company Limited (TSE code 4502) Add to Reading List Source URL: www.takeda.com Language: English - Date: 2014-10-30 01:30:46 Benzimidazoles Takeda Pharmaceutical Company Carboxylic acids Pharmaceutical industry Millennium Pharmaceuticals Takeda Candesartan Nycomed Dexlansoprazole Chemistry Organic chemistry Pharmacology
410	As of October 30, 2014 III. Pipeline 1. Development Activities Add to Reading List Source URL: www.takeda.com Language: English - Date: 2014-10-30 01:32:29 Targeted therapy Angiogenesis Influenza vaccine Breast cancer treatment Medicine Pharmacology Protein kinase inhibitor

UPDATE